Tesaro won’t reveal price of ovarian cancer drug. But it’ll likely be near $14,000 a month By: MarketWatch March 28, 2017 at 11:32 AM EDT The company could be delaying price information because it’ll be higher than expected, according to some. Read More >> Related Stocks: Astrazeneca Plc ADR Biogen Idec Clovis Oncology Inc Ionis Pharmaceuticals Range Cancer Therapeutics Index Tesaro Inc
